Guy’s and St Thomas’ Hospital: against COVID-19 Hospital

Entity: Guy’s and St Thomas’s Hospital

Category: Hospital

Description: Guy's Hospital in London Bridge, and St Thomas' Hospital in Waterloo are part of Guy's and St Thomas' NHS Foundation Trust. They provide patients with excellent treatment and care from two central London sites. Guy's and St Thomas' NHS Foundation Trust is an NHS foundation trust of the English National Health Service, one of the prestigious Shelford Group. Guy’s and St Thomas’ is one of the largest hospital trusts in the country, with around 17,100 staff; 25,650 Foundation trust members; an annual turnover of almost £1.6 billion; and 2.6 million patient contacts a year. Guy's Hospital was first established as an NHS Trust including University Hospital Lewisham but in 1993 Lewisham became independent and Guy's and St Thomas' joined together. In 2014 the Trust established ETL (Essentia Trading Limited), a unique multidisciplinary consultancy that enables public and private sector organisations to transform their environments and create a meaningful legacy. ETL re-invest profits within the Trust. ETL provides infrastructure advisory services in healthcare, higher education, science and research sectors across capital development, cost management, project and programme management, property consultancy, health strategy and planning and sustainability.

Project: Coronavirus treatment using convalescent plasma from recovered Covid-19 patients

Summary: A possible Coronavirus treatment using the plasma from recovered Covid-19 patients will be trialled by doctors at London’s Guy’s and St Thomas’s Hospital. The first donations of the plasma have been collected and transfusions will performed, the hospital’s Biomedical Research Centre said in a statement. The possible treatment, known as convalescent plasma, will help Covid-19 patients whose bodies are not producing enough antibodies to fight the disease.

Technology: COVID Labs/Universities
Headquarters: United Kingdom
Investment Stage: N/A
Number Of Exists: N/A
Founded Date: N/A
Industry: COVID R&D
Employee Number: N/A
Investor Type: N/A
Funding Status: N/A